News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi Pasteur (SASY.PA) (JOBS) Purchases Rights to Syntiron LLC's MRSA Vaccine; Sanofi Will Pay Syntiron Upfront Fee, Research Capital, and Several Milestone Payments That Could Reach $149 Million


12/16/2009 7:03:51 AM

Bookmark and Share

Bloomberg -- Sanofi-Aventis SA bought rights to a vaccine designed to prevent infection with Staphylococcus bacteria from closely held U.S. biotechnology company Syntiron.


comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES